Building strong partnerships to end the neglected tropical disease, schistosomiasis

Wednesday 4 May 12.30

Room 14

In English


Schistosomiasis is one of 20 Neglected Tropical Diseases affecting 1.7 billion people world-wide, mostly the very poor und vulnerable. Eliminating the disease as a public health problem is fundamental for people to lift themselves out of poverty. This endeavor requires strong partnerships in global health.

As the leader in the fight against schistosomiasis, we, at Merck, want to engage with partners in our purpose of creating, improving and prolonging lives through our global health responsibility to contribute to the elimination of this disease, as a public health burden, by 2030.


Manfred Klevesath

Head of Global Health, Bioethics & Digital Ethics, Merck

Jutta Reinhard-Rupp
Head of the Global Health Institute, Merck
Johannes Waltz
Head of the Merck Schistosomiasis Elimination Program


Daniel Argaw Dagne

Unit Head, Prevention, Treatment and Care, WHO Department of Control of Neglected Tropical Diseases

Sam Mayer

Vice President, Public Affairs, The END Fund

Sarah Nogaro

Principal Scientist, FIND (Foundation for Innovative New Diagnostics)

Okba Haj-Ali

Global Health Clinical Lead, Merck – on behalf of the Pediatric Praziquantel Consortium

Maurice Odiére

Principal Research Scientist, KEMRI (Kenya Medical Research Institute)

Jürg Utzinger
Director of the Swiss Tropical & Public Institute & Professor of Epidemiology at the University of Basel
Beatrice Greco

Head of R&D and Access at the Global Health Institute, Merck

Organized by